Overview

Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study was to evaluate the safety and intraocular pressure (IOP)-lowering efficacy of anecortave acetate for treatment of elevated IOP in patients with open-angle glaucoma.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Alcon Research
Treatments:
Anecortave
Hydrocortisone
Criteria
Inclusion Criteria:

- Diagnosis of open-angle glaucoma;

- Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

- Pseudoexfoliation;

- Pigment dispersion component;

- Other protocol-defined exclusion criteria may apply.